Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
ECM-receptor interaction | R-HSA-373711 | map04512 | etanidazole | 3276 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | bacitracin | 47641 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | bacitracin | 47641 | drug-path |
Nucleotide excision repair | R-HSA-5696398 | map03420 | bacitracin | 47641 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | bacitracin | 47641 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | mepenzolate bromide | 6461 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | mepenzolate bromide | 6461 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | mepenzolate bromide | 6461 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | mepenzolate bromide | 6461 | drug-path |
Glioma | Q9NZM4 | map05214 | mepenzolate bromide | 6461 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | mepenzolate bromide | 6461 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mepenzolate bromide | 6461 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | mepenzolate bromide | 6461 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | mepenzolate bromide | 6461 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | mepenzolate bromide | 6461 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | epitiostanol | 443935 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | epitiostanol | 443935 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | epitiostanol | 443935 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | epitiostanol | 443935 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | epitiostanol | 443935 | drug-path |